Diamondback Drugs - Ownership and Business Overview

Consumer ServicesCompany

Diamondback Drugs Ownership

Who owns Diamondback Drugs?

Diamondback Drugs is owned by Wedgewood Pharmacy. It was acquired on July 24, 2018.

Was Diamondback Drugs formerly PE-backed?

Yes. Diamondback Drugs was formerly owned by 2 private investors.

Diamondback Drugs Business Overview

Where is Diamondback Drugs headquartered?

Diamondback Drugs is headquartered in Scottsdale, Arizona.

What sector is Diamondback Drugs in?

Diamondback Drugs is a consumer services company.

When was Diamondback Drugs founded?

Diamondback Drugs was founded in 2001.

Consumer Services M&A Summary in 2018

Out of 60 sectors in the Mergr database, consumer services ranked 20 in number of deals in 2018. The largest consumer services acquisition in 2018 was Regal Entertainment Group - which was acquired by Cineworld Group for $2.5B.

Join Mergr to view all 110 acquisitions of consumer services companies in 2018, including 44 acquisitions by private equity firms, and 66 by strategics.

Diamondback Drugs LLC

7316 East Thomas Road,
Scottsdale, Arizona 85251
United States,
(480) 946-2223
www.diamondbackdrugs.com

Diamondback Drugs LLC is a veterinary compounding pharmacy that distributes pharmaceutical products to individual pet owners, veterinary offices and clinics. The company's compounding facility allows Diamondback to provide a broad veterinary compounded pharmaceutical offering, ranging from anti-infectives and ophthalmic preparations to cancer treatment solutions. Diamondback has grown from a small veterinary compounder into a growing platform serving pets in 50 states, as well as Canada and Mexico.


 Subscribe to unlock this and 201,688
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.